LCTX · Lineage Cell Therapeutics, Inc. · Fails to Deliver
$1.00
+0.02 (+1.52%)
At close · Oct 23
View the 10-K filed Mar 5, 2026
Return incl. dividend (before tax)
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$252.91M
Shares
252.91M
Volume · Oct 23
1.15M
Avg daily vol (3M)
1.25M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-29 | 8,789 | $0.97 | $8,525 |
| 2026-09-21 | 13,413 | $1.03 | $13,815 |
| 2026-09-18 | 311 | $1.03 | $320 |
| 2026-09-17 | 1,968 | $1.07 | $2,106 |
| 2026-09-16 | 1,968 | $1.06 | $2,086 |
| 2026-09-11 | 187 | $1.02 | $191 |
| 2026-09-10 | 1,817 | $1.03 | $1,872 |
| 2026-09-03 | 10 | $1.11 | $11 |
| 2026-09-02 | 775 | $1.08 | $837 |
| 2026-08-27 | 15,053 | $1.12 | $16,859 |
| 2026-08-21 | 53 | $1.08 | $57 |
| 2026-08-20 | 14 | $1.10 | $15 |
| 2026-08-12 | 205 | $1.12 | $230 |
| 2026-08-11 | 376 | $1.13 | $425 |
| 2026-08-10 | 284 | $1.10 | $312 |
| 2026-08-07 | 116 | $1.13 | $131 |
| 2026-08-04 | 43,612 | $1.11 | $48,409 |
| 2026-08-03 | 18 | $1.08 | $19 |
| 2026-07-31 | 68 | $1.11 | $75 |
| 2026-07-30 | 2,027 | $1.06 | $2,149 |
| 2026-07-29 | 666 | $1.07 | $713 |
Showing 1–21 of 21 settlements
Key facts
CIK
876343
CUSIP
53566P109
13F (30d)
26 filings
26 filers
Visit website
Investor relations